http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101337672-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 |
| filingDate | 2011-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101337672-B1 |
| titleOfInvention | A composition for the prevention and treatment of kidney stones comprising beta-D-glucose pentakis (3,4-dihydroxy-5-((3,4,5-trihydroxybenzoyl) oxy) benzoate) as an active ingredient |
| abstract | The present invention prevents and treats kidney stones comprising beta-D-glucose pentacis (3,4-dihydroxy-5-((3,4,5-trihydroxybenzoyl) oxy) benzoate) as an active ingredient. The composition for the present invention, the composition of the present invention can be used for the prevention and treatment of kidney stones by inhibiting the migration of kidney cells, inhibit the growth of calcium hydroxide crystals, inhibit the absorption of calcium hydroxide crystals in kidney cells . |
| priorityDate | 2011-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 102.